Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13809)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 28, 2016 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yashiro M, Matsuoka T. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer. World J Gastroenterol 2016; 22(8): 2415-2423 [PMID: 26937130 DOI: 10.3748/wjg.v22.i8.2415] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i8/2415.htm |
| Number | Citing Articles |
| 1 |
Ya-Kun Jiang, Wei Li, Ying-Yang Qiu, Meng Yue. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer. World Journal of Gastrointestinal Oncology 2024; 16(6): 2318-2334 doi: 10.4251/wjgo.v16.i6.2318
Abstract(179) |
Core Tip(189) |
Full Article(HTML)(1023)
|
Full Article with Cover (PDF)-10337K(38)
|
Audio-441K(3)
|
Peer-Review Report-231K(19)
|
Answering Reviewers-70K(17)
|
Supplementary Material-8723K(20)
|
Full Article (PDF)-10027K(62)
|
Full Article (XML)-321K(22)
|
Times Cited (0)
|
Total Visits (1894)
|
Open
|
| 2 |
Jun Wu, Wei Han, Weiwei Yang, Hongyu Liu, Chunhong Li, Ling Guo, Yan Jin, Ruijie Zhang, He Chen. Keratinocyte growth factor binding to fibroblast growth factor receptor 2-IIIb promotes epithelial ovarian cancer cell proliferation and invasion. Journal of Cancer Research and Therapeutics 2018; 14(Suppl 2): S347 doi: 10.4103/0973-1482.235353
|
| 3 |
Vincenzo Canzonieri, Federica Rao, Tiziana Perin, Lara Alessandrini, Angela Buonadonna, Giulio Bertola, Claudio Belluco, Renato Cannizzaro, Antonino De Paoli, Antonio Giordano. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 83 doi: 10.1007/978-3-030-04861-7_5
|
| 4 |
Z Ousati Ashtiani, J Tavakkoly-Bazzaz, SA Salami, MR Pourmand, F Mansouri, R Mashahdi, G Pourmand. Differential expression of FGFRs signaling pathway components in bladder cancer: A step toward personalized medicine. Balkan Journal of Medical Genetics 2017; 20(2): 75 doi: 10.1515/bjmg-2017-0026
|
| 5 |
Tasuku Matsuoka, Masakazu Yashiro. Biomarkers of gastric cancer: Current topics and future perspective. World Journal of Gastroenterology 2018; 24(26): 2818-2832 doi: 10.3748/wjg.v24.i26.2818
|
| 6 |
Navid Sobhani, Anna Ianza, Alberto D’Angelo, Giandomenico Roviello, Fabiola Giudici, Marina Bortul, Fabrizio Zanconati, Cristina Bottin, Daniele Generali. Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer. Cells 2018; 7(7): 76 doi: 10.3390/cells7070076
|
| 7 |
Navid Sobhani, Chunmei Fan, Pedro O. Flores-Villanueva, Daniele Generali, Yong Li. The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments. International Journal of Molecular Sciences 2020; 21(6): 2011 doi: 10.3390/ijms21062011
|
| 8 |
Loredana Amoroso, Marzia Ognibene, Martina Morini, Massimo Conte, Andrea Di Cataldo, Annalisa Tondo, Paolo D'Angelo, Aurora Castellano, Alberto Garaventa, Vito A. Lasorsa, Marina Podestà, Mario Capasso, Annalisa Pezzolo. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients. Genes, Chromosomes and Cancer 2020; 59(5): 277 doi: 10.1002/gcc.22827
|
| 9 |
Marina Alekseevna Senchukova. Origen, morfología y significancia clínica de microvesículas de tumor en cáncer gástrico. Magna Scientia UCEVA 2022; 2(1): 5 doi: 10.54502/msuceva.v2n1a2
|
| 10 |
Hideki Yamaguchi, Yuko Nagamura, Makoto Miyazaki. Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream Effectors. Cancers 2022; 14(15): 3750 doi: 10.3390/cancers14153750
|
| 11 |
Giuseppe Tirino, Luca Pompella, Angelica Petrillo, Maria Maddalena Laterza, Annalisa Pappalardo, Marianna Caterino, Michele Orditura, Fortunato Ciardiello, Gennaro Galizia, Ferdinando De Vita. What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives. International Journal of Molecular Sciences 2018; 19(9): 2659 doi: 10.3390/ijms19092659
|
| 12 |
José Pedro Santos, Joana Figueiredo, José Carlos Machado. Gastric Cancer Genetics and Its Implications for Diagnosis, Prognosis, and Treatment of the Disease. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2024; 24(2): 103 doi: 10.7704/kjhugr.2024.0018
|
| 13 |
Hyunjin Kim, Sujin Park, So Young Kang, Soomin Ahn, Kyoung-Mee Kim. Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden. Diagnostics 2022; 12(10): 2355 doi: 10.3390/diagnostics12102355
|
| 14 |
Masaru Katoh. Fibroblast growth factor receptors as treatment targets in clinical oncology. Nature Reviews Clinical Oncology 2019; 16(2): 105 doi: 10.1038/s41571-018-0115-y
|
| 15 |
Xin He, Zongguo Pang, Xianliang Zhang, Ting Lan, Huijiao Chen, Min Chen, Hong Yang, Juan Huang, Yihua Chen, Zhang Zhang, Wenyi Jing, Ran Peng, Hongying Zhang. Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma. American Journal of Surgical Pathology 2018; 42(9): 1143 doi: 10.1097/PAS.0000000000001125
|
| 16 |
Ousman Mohammed, Solomon Tebeje Gizaw, Maria Degef. Potential diagnostic, prognostic, and predictive biomarkers of gastric cancer. Health Science Reports 2024; 7(7) doi: 10.1002/hsr2.2261
|
| 17 |
Waleed A. Mohamed, Mona F. Schaalan, Basma Ramadan. The expression profiling of circulating miR‐204, miR‐182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer. Journal of Cellular Biochemistry 2019; 120(8): 13464 doi: 10.1002/jcb.28620
|
| 18 |
Maria Bogdan, Andreea-Daniela Meca, Adina Turcu-Stiolica, Carmen Nicoleta Oancea, Roxana Kostici, Marin Valeriu Surlin, Cristina Florescu. Insights into the Relationship between Pentraxin-3 and Cancer. International Journal of Molecular Sciences 2022; 23(23): 15302 doi: 10.3390/ijms232315302
|
| 19 |
Charline M. Sangany, Jagidesa Moodley, Onankoy A. Onyagunga, Thajasvarie Naicker. Role of basic fibroblast growth factor in human immunodeficiency virus associated pre‐eclampsia. Journal of Obstetrics and Gynaecology Research 2020; 46(8): 1292 doi: 10.1111/jog.14335
|
| 20 |
Barani Karikalan, Srikumar Chakravarthi. Target Therapy and Immunotherapy for Gastric Cancer - Recent Updates. Current Cancer Therapy Reviews 2022; 18(3): 202 doi: 10.2174/1573394718666220418095954
|
| 21 |
Fengjiao Wang, Xuexin Li, Xingkai Zhao, Yingwei Xue. Detection of a 5-circRNA signature to improve prognostic prediction in gastric cancer. Journal of Investigative Medicine 2020; 68(3): 762 doi: 10.1136/jim-2019-001131
|
| 22 |
Kenji Kuroda, Masakazu Yashiro, Yuichiro Miki, Tomohiro Sera, Yurie Yamamoto, Atsushi Sugimoto, Sadaaki Nishimura, Shuhei Kushiyama, Shingo Togano, Tomohisa Okuno, Masaichi Ohira. Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor. Cancer Science 2020; 111(12): 4500 doi: 10.1111/cas.14654
|
| 23 |
Larissa Maria Scalon Lemos, Oluwakemi Adekunbi Ọlọ́ba-Whẹ̀nù, Idris Abiodun Olasupo, Sikiru Olaitan Balogun, Antonio Macho, Eduarda Pavan, Domingos Tabajara de Oliveira Martins.
Brasiliensic acid:
in vitro
cytotoxic and genotoxic,
in vivo
acute toxicity and
in silico
pharmacological prediction of a new promising molecule
. Journal of Biomolecular Structure and Dynamics 2023; : 1 doi: 10.1080/07391102.2023.2280713
|
| 24 |
Salem Kim, Afsaneh Barzi, Lakshmi Rajdev. Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignancies. Seminars in Oncology 2018; 45(3): 133 doi: 10.1053/j.seminoncol.2018.03.001
|
| 25 |
D. S. Mikhaylenko, B. Y. Alekseev, D. V. Zaletaev, R. I. Goncharova, M. V. Nemtsova. Structural Alterations in Human Fibroblast Growth Factor Receptors in Carcinogenesis. Biochemistry (Moscow) 2018; 83(8): 930 doi: 10.1134/S0006297918080059
|
| 26 |
Kate Crawford, Erin Bontrager, Margaret A. Schwarz, Apurva Chaturvedi, Daniel D. Lee, Hassan Md Sazzad, Urs von Holzen, Changhua Zhang, Roderich E. Schwarz, Niranjan Awasthi. Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models. Cancer Biology & Therapy 2021; 22(10-12): 619 doi: 10.1080/15384047.2021.2011642
|
| 27 |
Sadaaki Nishimura, Masakazu Yashiro, Tomohiro Sera, Yurie Yamamoto, Yukako Kushitani, Atsushi Sugimoto, Shuhei Kushiyama, Shingo Togano, Kenji Kuroda, Tomohisa Okuno, Yoshiki Murakami, Masaichi Ohira.
Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells. Carcinogenesis 2020; 41(11): 1616 doi: 10.1093/carcin/bgaa031
|
| 28 |
Marina A Senchukova. Issues of origin, morphology and clinical significance of tumor microvessels in gastric cancer. World Journal of Gastroenterology 2021; 27(48): 8262-8282 doi: 10.3748/wjg.v27.i48.8262
|
| 29 |
Masakazu Yashiro, Kenji Kuroda, Go Masuda, Tomohisa Okuno, Yuichiro Miki, Yurie Yamamoto, Tomohiro Sera, Atsushi Sugimoto, Shuhei Kushiyama, Sadaaki Nishimura, Shingo Togano, Masaichi Ohira. Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84107-x
|